Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics

Over the past decade, more interests have been aroused in engineering protein-based nanoformulations for cancer treatment. This excitement originates from the success of FDA approved Abraxane (Albumin-based paclitaxel nanoparticles) in 2005. The new generation of biocompatible endogenous protein-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Yi, Miao, Dandan, Zhou, Min, Wang, Lijuan, Zhou, Hongyu, Su, Gaoxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934525/
https://www.ncbi.nlm.nih.gov/pubmed/29755355
http://dx.doi.org/10.3389/fphar.2018.00421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934525/
https://www.ncbi.nlm.nih.gov/pubmed/29755355
http://dx.doi.org/10.3389/fphar.2018.00421

Ejemplares similares